Skip to main content
Clinical Trials/DRKS00020411
DRKS00020411
Recruiting
未知

Multimodal physiotherapy as an add-on treatment to botulinum neurotoxin type A therapy in patients with cervical dystonia: a multicenter, single-blind, randomized, controlled study - DysPT-MULTI

eurologie Universitätsklinikum Jena0 sites224 target enrollmentJanuary 21, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
G24.3
Sponsor
eurologie Universitätsklinikum Jena
Enrollment
224
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 21, 2020
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
eurologie Universitätsklinikum Jena

Eligibility Criteria

Inclusion Criteria

  • CD diagnosed classifiable with Col/Cap\-classification (see also EC)
  • \- Continuously treated with BoNT\-A (Abobotulinumtoxin A) in three months interval (aiming to prevent bias by using different BoNT\-A\-products with different dosing strategies)
  • \- At least 12 months treatment without relevant BoNT\-A scheme changes over the last 3 injections

Exclusion Criteria

  • \- CD with Antecollis/\-caput only
  • \- CD without dystonic symptom (only tremor)
  • \- Contraindications for physiotherapy treatment
  • \- Contraindications for BoNT\-A treatment
  • \- Refusal of study participation or simultaneous participation in other studies

Outcomes

Primary Outcomes

Not specified

Similar Trials